A Novel Microspheres Formulation of Puerarin: Pharmacokinetics Study and In Vivo Pharmacodynamics Evaluations

Figure 5

Effects of Pue-CCMs on histopathological changes in rat hearts stained with H&E. Representative sections (magnification: 40×) are from the hearts of control (a), model (b), propranolol (c), Pue-CCMs (d), and puerarin (e).

(a)

(b)

(c)

(d)

(e)